Clinical use of novel biomarkers in heart failure: towards personalized medicine. - Wikidata - wikimedia - TriplyDB

Clinical use of novel biomarkers in heart failure: towards personalized medicine.

Clinical use of novel biomarkers in heart failure: towards personalized medicine.

http://www.wikidata.org/entity/Q38109588

about

Soluble ST2 and Galectin-3: What We Know and Don't Know Analytically.Clinical utility of antigen carbohydrate 125 in heart failure.Prediction of clinical outcomes using B-type natriuretic peptides in the general population: a systematic review.Proteomics of pediatric heart failure: from traditional biomarkers to new discovery strategies.Identifying Subpopulations with Distinct Response to Treatment Using Plasma Biomarkers in Acute Heart Failure: Results from the PROTECT Trial : Differential Response in Acute Heart Failure.Galectin-3 induces cell migration via a calcium-sensitive MAPK/ERK1/2 pathway.Plasma biomarkers to predict or rule out early post-discharge events after hospitalization for acute heart failure.A multimarker multi-time point-based risk stratification strategy in acute heart failure: results from the RELAX-AHF trial.A systems BIOlogy Study to TAilored Treatment in Chronic Heart Failure: rationale, design, and baseline characteristics of BIOSTAT-CHF.Labeling galectin-3 for the assessment of myocardial infarction in rats.Optimizing clinical use of biomarkers in high-risk acute heart failure patients.Biomarker Profiles in Heart Failure Patients With Preserved and Reduced Ejection Fraction.Biomarkers and personalized therapy in chronic kidney diseases.Palliative Care in the Management of Patients with Advanced Heart Failure.Biomarkers, myocardial fibrosis and co-morbidities in heart failure with preserved ejection fraction: an overview.

P2860

Q37229321-D80ADE35-0843-4606-BF97-B7B5E0D3E504 Q38127350-9ED87F6C-DB22-4832-ADA8-93AF961E36B1 Q38232810-009FACE0-D037-4B92-913E-5F64A7B08F93 Q38588156-66A8EBAD-C0B3-48FB-8F94-EC92B93DFD5B Q38705811-0ACC3A31-762F-48F5-824B-CAE13297AD1B Q40084619-899DF210-2853-48EA-A4AA-CCD7F7EAED28 Q40311889-FDEC0407-64DA-43CB-A92C-8531B74441C6 Q40359671-2B3D65A7-0670-41E6-BDEF-18B2262F9917 Q40777024-691F083D-BF40-4D15-B73F-FDD567F3B83A Q40792117-8E80B94D-4219-4894-891F-EB3C692E0A68 Q41074638-282323DD-8A2B-4945-9296-A22B6ABDBE0C Q41165768-AA374A92-68DD-49DE-A056-F770A933103F Q42662118-863F9299-2156-4FCD-A000-A166D1D7C3A7 Q47739995-5BAE3B29-BEA0-4D64-B612-4B8487376595 Q55610979-2B364FBF-2065-46E1-955F-9C9070319503

P2860

Clinical use of novel biomarkers in heart failure: towards personalized medicine.

http://www.wikidata.org/entity/Q38109588

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Clinical use of novel biomarkers in heart failure: towards personalized medicine.

@en

type

label

Clinical use of novel biomarkers in heart failure: towards personalized medicine.

@en

prefLabel

Clinical use of novel biomarkers in heart failure: towards personalized medicine.

@en

P1433

Q38109588-E5377347-7BFF-4E75-B7C0-CBEEE3D1830F

P1476

Q38109588-1071C82D-D141-49C8-ACF7-2695AAAC4B3F

P2093

Q38109588-EB8C952A-5F88-40D6-9AD1-B524E2DA97EC

Q38109588-FBF82D65-84DD-4D74-A186-120D1B33FCC0

P2860

Q38109588-00EB0489-2EB7-4F6F-A738-0CAC69EF44E7

Q38109588-010CD43D-297D-48D5-B96C-E4B14C08D752

Q38109588-017A1709-6499-4F48-A27E-356820819872

Q38109588-0650F0BD-587D-4E79-B59C-BD345CF073DA

Q38109588-15424108-FA56-4018-80D9-DC1F1AA13C18

Q38109588-15A18B54-72E2-4047-909E-18E3C2059F62

Q38109588-16F1B5DF-B073-47DF-B4C3-14C40D169DE0

Q38109588-24BA403D-9339-4856-A958-1886F91C3A81

Q38109588-2F77539B-6B26-4983-96E7-B3E5BBF1D9F3

Q38109588-3111F4AB-9085-48E8-AE40-C745DC40D7E8

P2888

Q38109588-099F0F01-AAAA-4412-86E3-311F376C6692

P304

Q38109588-A3FAED02-7B4B-4B3E-88BD-D5A95AC1631A

P31

Q38109588-EC9D003D-9207-495C-AF97-73EBA5E6D487

P356

Q38109588-EA179C4F-36ED-4A97-93CB-D9C119238A64

P433

Q38109588-DEE4B519-41B6-47A7-AC4E-06C4F5D691D9

P478

Q38109588-664199E8-178E-4B98-B195-356ABB9EB534

P50

Q38109588-2E136B77-C42C-45A1-A151-AE2E9438B733

P577

Q38109588-88B70E45-23FE-459D-8105-68C2DFB12CD4

P698

Q38109588-7AE40E67-B788-47A9-B89E-63C9BA612E66

P921

Q38109588-D7A9F1F8-0565-480F-BDE7-66BBCF16EB61

Q38109588-F0586385-0397-47D7-9EBC-6A3B4A62FA06

P356

S10741-013-9396-5

P1433

Heart Failure Reviews

P1476

Clinical use of novel biomarkers in heart failure: towards personalized medicine.

@en

P2093

Adriaan A Voors

http://www.w3.org/2001/XMLSchema#string

Daniela Schmitter

http://www.w3.org/2001/XMLSchema#string

P2860

Galectin-3 regulates myofibroblast activation and hepatic fibrosis

The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1

Silencing of microRNAs in vivo with 'antagomirs'

Effect of nesiritide in patients with acute decompensated heart failure

Serial sampling of ST2 predicts 90-day mortality following destabilized heart failure

MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts

Soluble ST2 for predicting sudden cardiac death in patients with chronic heart failure and left ventricular systolic dysfunction.

The predictive value of stable precursor fragments of vasoactive peptides in patients with chronic heart failure: data from the GISSI-heart failure (GISSI-HF) trial.

Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: data from the DEAL-HF study.

MicroRNA-133a protects against myocardial fibrosis and modulates electrical repolarization without affecting hypertrophy in pressure-overloaded adult hearts

P2888

s10741-013-9396-5

P304

369-381

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10741-013-9396-5

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23709316

http://www.w3.org/2001/XMLSchema#string

P921